Scientific & Research Collaborations

We are your scientific partner of choice.

CollaboratorDrug CandidateDisease
Dana-farber cancer instituteFimepinostatChildren and Young Adults with Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
pacific pediatric neuro-oncology consortiumFimepinostatChildren and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG), Recurrent Medulloblastoma, or Recurrent High-Grade Glioma (HGG)
curis divider

Investigators may request Curis to provide its compounds for clinical and non-clinical study purposes. For non-clinical studies, we request a Material Transfer Agreement (MTA) and the Sponsor Research Agreement (SRA).

Investigator-Sponsored Trial (IST) or Investigator-Initiated Trial (IIT)

Similar to clinical studies, IST or IIT studies provide qualifying patients with access to investigational drugs. Data is collected to better understand safety and efficacy where the sponsor-investigator assumes responsibility for all aspects of the research.

For IST or IIT requests by physicians click here

Material Transfer Agreement (MTA)

A request by an external entity (e.g. academic or research institution) to conduct research and/or collaborate on a Curis compound. Only compound material will be provided for this agreement.

For an MTA Request click here

Sponsor Research Agreement (SRA)

A request by an external entity (e.g. academic or research institution) to conduct research and/or collaborate on a Curis compound. This request includes funding to support the research plan.

For an SRA request click here